Home Industries Reports Services About Us Publisher Contact us
Home / Reports / Pharma & Healthcare / Nuclear Medicine Radioisotopes Market By Type Of Radioisotopes Technetium 99m Tc 99m Thallium 201

Nuclear Medicine Radioisotopes Market By Type of Radioisotopes (Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Fluorine-18, Rubidium-82 (Rb-82), Iodine-131 (I-131), Lutetium-177 (Lu-177), Radium-223 (Ra-223) and Alpharadin, Actinium-225 (Ac-225), Other Types of Radioisotopes), Application (Oncology, Cardiology, Thyroid, Neurology, Other Applications), Regions, Global Industry Analysis, Share, Growth, Trends, and Forecast 2020 to 2027.

Covid-19 Impact on Nuclear Medicine Radioisotopes Market

Type: PDF

Status: Published

Categories: Pharma & Healthcare

Report Code : PHC21

No. of Pages : 350

A Nuclear Medicine Radioisotopes Market-Global Industry Trend & Analysis market 2027 report delivering a professional and detailed analysis of the market and it focuses on main factors, industry strategists and effective growth for key players. The research supports decision-makers in making cost-effective business decisions.

Using verified research procedures and assumptions, the forecasts highlighted in the market share study have been derived. The Nuclear Medicine Radioisotopes Market is thoroughly observed with the help of macroeconomic and microeconomic factors.

Based on the detailed research, the Nuclear Medicine Radioisotopes Market report studies the past and evaluates future opportunities. It is a source of key factors that are responsible for the global market's growth. The report offers granular, robust qualitative data on how the market is evolving and quantitative market outlooks.

The aim of the market report is to meet the requirements of the end-user customer and enable them to frame business strategies that will help them enter the market even deeper. To establish a business strategy and improve profitability, the Nuclear Medicine Radioisotopes Market report covers all the critical information needed. The key players covered in the global market report:

Company Profiling

The Nuclear Medicine Radioisotopes Market study covers the competitive situation among the industry players and includes market price analysis and value chain features. The following players are listed in the report:The study provides detailed profiling of these companies. The information product portfolio, revenue analysis, business overview, and any recent developments related to the market.

  • Bayer AG
  • Bracco SpA
  • Cardinal Health Inc.
  • China Isotope & Radiation Corporation (CIRC)
  • Curium
  • Lantheus Medical Imaging Inc.
  • GE Healthcare
  • NTP Radioisotopes SOC Ltd
  • Fujifilm Holdings Corporation
  • Sotera Health (Nordion Inc.)

Important report coverage:

Summarizing the Nuclear Medicine Radioisotopes Market industry drivers, challenges and strategies adopted:

The report offers a detailed analysis of key factors affecting the growth of the Nuclear Medicine Radioisotopes Market industry, such as threats, barriers to entry, drivers, challenges, opportunities and competitive strategy that provides the reader with a robust judgement that can help shape their own business policies and strategies.

The study includes an in-depth analysis of the SWOT analysis, PORTER’s five forces analysis, and PESTEL analysis to offer business-related data and information. The SWOT analysis helps the customer to identify both the positive and negative attributes of the Nuclear Medicine Radioisotopes Market. The PORTER’s and PESTEL’s analysis affects the growth and development of the company to maintain and sustain in the long term.

In addition, the study sheds light on upstream raw materials, marketing channels, downstream customer survey, industry development trends and recommendations that specifically provide useful information on key manufacturing equipment suppliers, major distributors, raw materials suppliers, and major customers with their contact information.

The report provides insights on the following pointers:

  1. Market Development: Offers detailed information about emerging markets and analyzes the markets for the Global Nuclear Medicine Radioisotopes Market.
  2. Market Penetration: Provides extensive information offered by the key players in the Global Nuclear Medicine Radioisotopes Market.
  3. Competitive Assessment & Intelligence: Provides an exhaustive assessment of products, strategies, market shares, and manufacturing capabilities of the prominent players in the Global Nuclear Medicine Radioisotopes Market
  4. Product Development & Innovation: Offers intelligent insights on future technologies, recent product developments, and R&D activities in the Global Nuclear Medicine Radioisotopes Market
  5. Market Diversification: Provides extensive information about recent developments, new products launch, emerging geographies, and investments in the Global Nuclear Medicine Radioisotopes Market

 

Market Segments:

The Nuclear Medicine Radioisotopes Market report in the following segments:

Nuclear Medicine Radioisotopes By Type of Radioisotopes Revenue 

  • Technetium-99m (Tc-99m)
  • Thallium-201 (Tl-201)
  • Iodine (I-123)
  • Fluorine-18
  • Rubidium-82 (Rb-82)
  • Iodine-131 (I-131)
  • Lutetium-177 (Lu-177)
  • Radium-223 (Ra-223) and Alpharadin
  • Actinium-225 (Ac-225)
  • Other Types of Radioisotopes

Nuclear Medicine Radioisotopes By Application Revenue 

  • Oncology
  • Cardiology
  • Thyroid
  • Neurology
  • Other Applications

Nuclear Medicine Radioisotopes By Region Revenue 

  • North America
    • U,S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Sweden
    • Russia
    • Switzerland
    • Netherlands
    • Rest Of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Indonesia
    • Australia
    • Vietnam
    • New Zealand
    • Philippines
    • South Korea
    • Taiwan
    • Singapore
    • Rest Of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Rest Of South America
  • Middle East & Africa
    • South Africa
    • U.A.E.
    • Saudi Arabia
    • Rest Of Middle East And Africa

 

The report answers questions such as:

  1. What is the Global Nuclear Medicine Radioisotopes Market’s competitive position?
  2. What is the global Nuclear Medicine Radioisotopes Market’s size?
  3. What are the factors driving the growth in the Global Nuclear Medicine Radioisotopes Market over the forecast period?
  4. What are the opportunities of the Global Nuclear Medicine Radioisotopes Market?
  5. Which are the key product fields to be invested in during the projected period in the Global Nuclear Medicine Radioisotopes Market?

 

Request For Request Sample

To receive a sample copy of this report, please complete the form below

Kindly share your specific requirement (if any), so we can get back to you with a solution

TABLE OF CONTENTS
1.    INTRODUCTION 
1.1. OBJECTIVES OF THE STUDY 
1.2. SCOPE OF THE STUDY
1.3. GEOGRAPHIC SCOPE 
1.4. MARKET DEFINITION 
1.5. CURRENCY CONSIDERATION 
1.6. YEAR CONSIDERATION 
2.    RESEARCH METHODOLOGY AND ASSUMPTIONS
2.1. SECONDARY RESEARCH
2.2. PRIMARY RESEARCH 
2.3. MARKET BREAKUP AND DATA TRIANGULATION
2.4. MARKET SIZE ESTIMATION
2.4.1. BOTTOM UP APPROACH
2.4.2. TOP DOWN APPROACH
2.5. ASSUMPTION 
3.    EXECUTIVE SUMMARY
3.1. KEY MARKET INSIGHTS 
3.2. SEGMENTATION OUTLOOK
3.3. COMPANY OUTLOOK
4.    PREMIUM INSIGHTS
4.1. IMPACT OF COVID-19 ON MARKET
4.2. INDUSTRY ROAD MAP
4.3. INDUSTRY TREND
4.4. INDUSTRY SWOT ANALYSIS 
4.5. MARKET ATTRACTIVENESS ANALYSIS 
4.5.1. MARKET ATTRACTIVENESS BY SEGMENTS 
4.5.1.1. NUCLEAR MEDICINE RADIOISOTOPES MARKET ATTENTIVENESS BY APPLICATION
4.5.1.2. NUCLEAR MEDICINE RADIOISOTOPES MARKET ATTENTIVENESS BY TYPE OF RADIOISOTOPES
4.5.2. MARKET ATTRACTIVENESS BY REGION 
4.5.2.1.   NORTH AMERICA NUCLEAR MEDICINE RADIOISOTOPES MARKET ATTENTIVENESS BY COUNTRY
4.5.2.2. EUROPE NUCLEAR MEDICINE RADIOISOTOPES MARKET ATTENTIVENESS BY COUNTRY
4.5.2.3. ASIA PACIFIC NUCLEAR MEDICINE RADIOISOTOPES MARKET ATTENTIVENESS BY COUNTRY
4.5.2.4. SOUTH AMERICA NUCLEAR MEDICINE RADIOISOTOPES MARKET ATTENTIVENESS BY COUNTRY
4.5.2.5. MIDDLE EAST AND AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET ATTENTIVENESS BY COUNTRY
4.6. PORTER’S FIVE FORCES ANALYSIS 
4.6.1. THREAT OF NEW ENTRANTS
4.6.2. THREAT OF SUBSTITUTES
4.6.3. BARGAINING POWER OF SUPPLIERS
4.6.4. BARGAINING POWER OF BUYERS
4.6.5. INTENSITY OF COMPETITIVE RIVALRY
4.7. VALUE CHAIN ANALYSIS 
4.7.1. RESEARCH & DEVELOPMENT COMPANIES
4.7.2. RAW MATERIAL/ COMPONENT SUPPLIERS
4.7.3.  PRODUCT MANUFACTURERS
4.7.4. DISTRIBUTORS AND RETAILERS
4.7.5. END-USER INDUSTRIES
4.7.6. POST-SALES SERVICE PROVIDERS
4.8. FACTORS AFFECTING THE MARKET
4.8.1. MACRO FACTORS AFFECTING THE MARKET
4.8.2. MICRO FACTORS AFFECTING THE MARKET
4.8.3. PESTEL ANALYSIS 
4.9. YEAR ON YEAR GROWTH RATE OF NUCLEAR MEDICINE RADIOISOTOPES 
4.10. LIST OF SUPPLIERS 
4.11. LIST OF BUYERS 
4.12. COUNTRY LEVEL ANALYSIS 
4.13. RULES AND REGULATION 
5.    MARKET DYNAMICS
5.1. MARKET DRIVERS
5.2. MARKET RESTRAINTS
5.3. MARKET OPPORTUNITIES
5.4. MARKET CHALLENGES
6.    GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET INSIGHTS AND FORECAST ANALYSIS, BY TYPE OF RADIOISOTOPES - 2017-2027
6.1. KEY FINDINGS 
6.2. TECHNETIUM-99M (TC-99M)
6.3. THALLIUM-201 (TL-201)
6.4. IODINE (I-123)
6.5. FLUORINE-18
6.6. RUBIDIUM-82 (RB-82)
6.7. IODINE-131 (I-131)
6.8. LUTETIUM-177 (LU-177)
6.9. RADIUM-223 (RA-223) AND ALPHARADIN
6.10. ACTINIUM-225 (AC-225)
6.11. OTHER TYPES OF RADIOISOTOPES
7.    GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET INSIGHTS AND FORECAST ANALYSIS, BY APPLICATION - 2017-2027
7.1. KEY FINDINGS 
7.2. ONCOLOGY
7.3. CARDIOLOGY
7.4. THYROID
7.5. NEUROLOGY
7.6. OTHER APPLICATIONS
8.    GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET INSIGHTS AND FORECAST ANALYSIS, BY REGIONAL - 2017-2027
8.1. KEY FINDINGS 
8.2. NORTH AMERICA
8.3. EUROPE
8.4. ASIA PACIFIC
8.5. SOUTH AMERICA
8.6. MIDDLE EAST & AFRICA
9.    NORTH AMERICA NUCLEAR MEDICINE RADIOISOTOPES MARKET INSIGHTS AND FORECAST ANALYSIS, BY SEGMENTS AND COUNTRY - 2017-2027
9.1. BY COUNTRY 
9.1.1. U.S.
9.1.2. CANADA
9.1.3. MEXICO
10.    EUROPE NUCLEAR MEDICINE RADIOISOTOPES MARKET INSIGHTS AND FORECAST ANALYSIS, BY SEGMENTS AND COUNTRY - 2017-2027
10.1. BY COUNTRY 
10.1.1. GERMANY
10.1.2. U.K.
10.1.3. FRANCE
10.1.4. ITALY
10.1.5. SPAIN
10.1.6. SWEDEN
10.1.7. BELGIUM
10.1.8. TURKEY
10.1.9. RUSSIA
10.1.10. POLAND
10.1.11. SWITZERLAND
10.1.12. NETHERLANDS
10.1.13. REST OF EUROPE
11.    ASIA PACIFIC NUCLEAR MEDICINE RADIOISOTOPES MARKET INSIGHTS AND FORECAST ANALYSIS, BY SEGMENTS AND COUNTRY - 2017-2027
11.1. BY COUNTRY 
11.1.1.1. JAPAN
11.1.1.2. CHINA
11.1.1.3. INDIA
11.1.1.4. AUSTRALIA
11.1.1.5. SOUTH KOREA
11.1.1.6. MALAYSIA
11.1.1.7. INDONESIA 
11.1.1.8. VIETNAM
11.1.1.9. NEW ZEALAND
11.1.1.10. PHILIPPINES
11.1.1.11. TAIWAN
11.1.1.12. SINGAPORE
11.1.1.13. REST OF ASIA-PACIFIC
12.    SOUTH AMERICA NUCLEAR MEDICINE RADIOISOTOPES MARKET INSIGHTS AND FORECAST ANALYSIS, BY SEGMENTS AND COUNTRY - 2017-2027
12.1. BY COUNTRY 
12.1.1.1. BRAZIL
12.1.1.2. ARGENTINA
12.1.1.3. CHILE
12.1.1.4. COLOMBIA
12.1.1.5. REST OF SOUTH AMERICA
13.    MIDDLE EAST & AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET INSIGHTS AND FORECAST ANALYSIS, BY SEGMENTS AND COUNTRY - 2017-2027
13.1. BY COUNTRY 
13.1.1.1. SOUTH AFRICA
13.1.1.2. U.A.E.
13.1.1.3. SAUDI ARABIA
13.1.1.4. REST OF MIDDLE EAST AND AFRICA
14.    COMPETITIVE LANDSCAPE
14.1. MARKET SHARE OF KEY PLAYERS IN POWER TOOL MARKET
14.1.1. GLOBAL MARKET SHARE ANALYSIS 
14.1.2. NORTH AMERICA MARKET SHARE ANALYSIS 
14.1.3. EUROPE MARKET SHARE ANALYSIS 
14.1.4. ASIA PACIFIC MARKET SHARE ANALYSIS 
14.1.5. SOUTH AMERICA MARKET SHARE ANALYSIS
14.1.6. MIDDLE EAST & AFRICA MARKET SHARE ANALYSIS
14.2. LEADERSHIP MAPPING
14.2.1. VISIONARY PLAYERS
14.2.2. INNOVATORS PLAYERS
14.2.3. DYNAMIC DIFFERENTIATORS
14.2.4. EMERGING COMPANIES
14.3. COMPETITIVE SCENARIO AND TRENDS
14.3.1. MERGERS & ACQUISITIONS
14.3.2. PRODUCT LAUNCHES AND DEVELOPMENTS
14.3.3. PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS
14.3.4. EXPANSIONS
15.    COMPANY PROFILES
15.1.1. BAYER AG
15.1.1.1. COMPANY OVERVIEW
15.1.1.2. COMPANY SNAPSHOT
15.1.1.3. FINANCIAL ANALYSIS
15.1.1.3.1.       REVENUE ANALYSIS 
15.1.1.3.2.    SALES ANALYSIS 
15.1.1.3.3.    PRICE ANALYSIS
15.1.1.3.4.    MARGIN ANALYSIS 
15.1.1.4. GEOGRAPHICAL PRESENCE
15.1.1.4.1.       NORTH AMERICA
15.1.1.4.2.    EUROPE
15.1.1.4.3.    ASIA PACIFIC
15.1.1.4.4.    SOUTH AMERICA
15.1.1.4.5.    MIDDLE EAST & AFRICA
15.1.1.5. PRODUCT PORTFOLIO
15.1.1.6. SWOT ANALYSIS
15.1.1.7. RECENT DEVELOPMENT
15.1.2. BRACCO SPA
15.1.3. CARDINAL HEALTH INC.
15.1.4. CHINA ISOTOPE & RADIATION CORPORATION (CIRC)
15.1.5. CURIUM
15.1.6. LANTHEUS MEDICAL IMAGING INC.
15.1.7. GE HEALTHCARE
15.1.8. NTP RADIOISOTOPES SOC LTD
15.1.9. FUJIFILM HOLDINGS CORPORATION
15.1.10. SOTERA HEALTH (NORDION INC.)
16.    STRATEGIC RECOMMENDATIONS
 
LIST OF TABLE
1.    RESEARCH ASSUMPTION 
2.    COVID-19 IMPACT ON MARKET
3.    MAJOR DEVELOPMENTS BY VARIOUS COMPANIES
4.    GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY TYPE OF RADIOISOTOPES, 2017–2027 REVENUE (USD MILLION) 
5.    GLOBAL TECHNETIUM-99M (TC-99M) NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY REGION, 2017–2027 REVENUE (USD MILLION)
6.    GLOBAL  IODINE (I-123) NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY REGION, 2017–2027 REVENUE (USD MILLION)
7.    GLOBAL THALLIUM-201 (TL-201) NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY REGION, 2017–2027 REVENUE (USD MILLION)
8.    GLOBAL  FLUORINE-18 NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY REGION, 2017–2027 REVENUE (USD MILLION)
9.    GLOBAL RUBIDIUM-82 (RB-82) NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY REGION, 2017–2027 REVENUE (USD MILLION)
10.    GLOBAL  IODINE-131 (I-131) NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY REGION, 2017–2027 REVENUE (USD MILLION)
11.    GLOBAL LUTETIUM-177 (LU-177) NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY REGION, 2017–2027 REVENUE (USD MILLION)
12.    GLOBAL  RADIUM-223 (RA-223) AND ALPHARADIN NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY REGION, 2017–2027 REVENUE (USD MILLION)
13.    GLOBAL  ACTINIUM-225 (AC-225) NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY REGION, 2017–2027 REVENUE (USD MILLION)
14.    GLOBAL  OTHER TYPES OF RADIOISOTOPES NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY REGION, 2017–2027 REVENUE (USD MILLION)
15.    GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY APPLICATION, 2017–2027 REVENUE (USD MILLION)
16.    GLOBAL ONCOLOGY NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY REGION, 2017–2027 REVENUE (USD MILLION)
17.    GLOBAL  CARDIOLOGY NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY REGION, 2017–2027 REVENUE (USD MILLION)
18.    GLOBAL THYROID NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY REGION, 2017–2027 REVENUE (USD MILLION)
19.    GLOBAL  NEUROLOGY NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY REGION, 2017–2027 REVENUE (USD MILLION)
20.    GLOBAL  OTHER APPLICATIONS NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY REGION, 2017–2027 REVENUE (USD MILLION)
21.    GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY NORTH AMERICA, 2017–2027 REVENUE (USD MILLION)
22.    NORTH AMERICA NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY TYPE OF RADIOISOTOPES, 2017–2027 REVENUE (USD MILLION)
23.    NORTH AMERICA NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY APPLICATION, 2017–2027 REVENUE (USD MILLION)
24.    U.S. NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY TYPE OF RADIOISOTOPES, 2017–2027 REVENUE (USD MILLION)
25.    U.S. NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY APPLICATION, 2017–2027 REVENUE (USD MILLION)
26.    CANADA NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY TYPE OF RADIOISOTOPES, 2017–2027 REVENUE (USD MILLION)
27.    CANADA NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY APPLICATION, 2017–2027 REVENUE (USD MILLION)
28.    MEXICO NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY TYPE OF RADIOISOTOPES, 2017–2027 REVENUE (USD MILLION)
29.    MEXICO NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY APPLICATION, 2017–2027 REVENUE (USD MILLION)
30.    EUROPE NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY TYPE OF RADIOISOTOPES, 2017–2027 REVENUE (USD MILLION)
31.    EUROPE NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY APPLICATION, 2017–2027 REVENUE (USD MILLION)
32.    GERMANY NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY TYPE OF RADIOISOTOPES, 2017–2027 REVENUE (USD MILLION)
33.    GERMANY NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY APPLICATION, 2017–2027 REVENUE (USD MILLION)
34.    FRANCE NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY TYPE OF RADIOISOTOPES, 2017–2027 REVENUE (USD MILLION)
35.    FRANCE NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY APPLICATION, 2017–2027 REVENUE (USD MILLION)
36.    U.K. NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY TYPE OF RADIOISOTOPES, 2017–2027 REVENUE (USD MILLION)
37.    U.K. NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY APPLICATION, 2017–2027 REVENUE (USD MILLION)
38.    ITALY NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY TYPE OF RADIOISOTOPES, 2017–2027 REVENUE (USD MILLION)
39.    ITALY NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY APPLICATION, 2017–2027 REVENUE (USD MILLION)
40.    SPAIN NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY TYPE OF RADIOISOTOPES, 2017–2027 REVENUE (USD MILLION)
41.    SPAIN NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY APPLICATION, 2017–2027 REVENUE (USD MILLION)
42.    SWEDEN NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY TYPE OF RADIOISOTOPES, 2017–2027 REVENUE (USD MILLION)
43.    SWEDEN NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY APPLICATION, 2017–2027 REVENUE (USD MILLION)
44.    BELGIUM NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY TYPE OF RADIOISOTOPES, 2017–2027 REVENUE (USD MILLION)
45.    BELGIUM NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY APPLICATION, 2017–2027 REVENUE (USD MILLION)
46.    TURKEY NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY TYPE OF RADIOISOTOPES, 2017–2027 REVENUE (USD MILLION)
47.    TURKEY NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY APPLICATION, 2017–2027 REVENUE (USD MILLION)
48.    RUSSIA NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY TYPE OF RADIOISOTOPES, 2017–2027 REVENUE (USD MILLION)
49.    RUSSIA NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY APPLICATION, 2017–2027 REVENUE (USD MILLION)
50.    POLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY TYPE OF RADIOISOTOPES, 2017–2027 REVENUE (USD MILLION)
51.    POLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY APPLICATION, 2017–2027 REVENUE (USD MILLION)
52.    SWITZERLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY TYPE OF RADIOISOTOPES, 2017–2027 REVENUE (USD MILLION)
53.    SWITZERLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY APPLICATION, 2017–2027 REVENUE (USD MILLION)
54.    NETHERLANDS NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY TYPE OF RADIOISOTOPES, 2017–2027 REVENUE (USD MILLION)
55.    NETHERLANDS NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY APPLICATION, 2017–2027 REVENUE (USD MILLION)
56.    ASIA PACIFIC NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY TYPE OF RADIOISOTOPES, 2017–2027 REVENUE (USD MILLION)
57.    ASIA PACIFIC NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY APPLICATION, 2017–2027 REVENUE (USD MILLION)
58.    JAPAN NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY TYPE OF RADIOISOTOPES, 2017–2027 REVENUE (USD MILLION)
59.    JAPAN NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY APPLICATION, 2017–2027 REVENUE (USD MILLION)
60.    CHINA NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY TYPE OF RADIOISOTOPES, 2017–2027 REVENUE (USD MILLION)
61.    CHINA NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY APPLICATION, 2017–2027 REVENUE (USD MILLION)
62.    INDIA NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY TYPE OF RADIOISOTOPES, 2017–2027 REVENUE (USD MILLION)
63.    INDIA NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY APPLICATION, 2017–2027 REVENUE (USD MILLION)
64.    AUSTRALIA NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY TYPE OF RADIOISOTOPES, 2017–2027 REVENUE (USD MILLION)
65.    AUSTRALIA NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY APPLICATION, 2017–2027 REVENUE (USD MILLION)
66.    SOUTH KOREA NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY TYPE OF RADIOISOTOPES, 2017–2027 REVENUE (USD MILLION)
67.    SOUTH KOREA NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY APPLICATION, 2017–2027 REVENUE (USD MILLION)
68.    INDONESIA  NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY TYPE OF RADIOISOTOPES, 2017–2027 REVENUE (USD MILLION)
69.    INDONESIA  NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY APPLICATION, 2017–2027 REVENUE (USD MILLION)
70.    VIETNAM NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY TYPE OF RADIOISOTOPES, 2017–2027 REVENUE (USD MILLION)
71.    VIETNAM NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY APPLICATION, 2017–2027 REVENUE (USD MILLION)
72.    NEW ZEALAND NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY TYPE OF RADIOISOTOPES, 2017–2027 REVENUE (USD MILLION)
73.    NEW ZEALAND NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY APPLICATION, 2017–2027 REVENUE (USD MILLION)
74.    PHILIPPINES NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY TYPE OF RADIOISOTOPES, 2017–2027 REVENUE (USD MILLION)
75.    PHILIPPINES NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY APPLICATION, 2017–2027 REVENUE (USD MILLION)
76.    TAIWAN NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY TYPE OF RADIOISOTOPES, 2017–2027 REVENUE (USD MILLION)
77.    TAIWAN NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY APPLICATION, 2017–2027 REVENUE (USD MILLION)
78.    SINGAPORE NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY TYPE OF RADIOISOTOPES, 2017–2027 REVENUE (USD MILLION)
79.    SINGAPORE NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY APPLICATION, 2017–2027 REVENUE (USD MILLION)
80.    SOUTH AMERICA NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY TYPE OF RADIOISOTOPES, 2017–2027 REVENUE (USD MILLION)
81.    SOUTH AMERICA NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY APPLICATION, 2017–2027 REVENUE (USD MILLION)
82.    BRAZIL NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY TYPE OF RADIOISOTOPES, 2017–2027 REVENUE (USD MILLION)
83.    BRAZIL NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY APPLICATION, 2017–2027 REVENUE (USD MILLION)
84.    ARGENTINA NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY TYPE OF RADIOISOTOPES, 2017–2027 REVENUE (USD MILLION)
85.    ARGENTINA NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY APPLICATION, 2017–2027 REVENUE (USD MILLION)
86.    CHILE NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY TYPE OF RADIOISOTOPES, 2017–2027 REVENUE (USD MILLION)
87.    CHILE NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY APPLICATION, 2017–2027 REVENUE (USD MILLION)
88.    COLOMBIA NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY TYPE OF RADIOISOTOPES, 2017–2027 REVENUE (USD MILLION)
89.    COLOMBIA NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY APPLICATION, 2017–2027 REVENUE (USD MILLION)
90.    MIDDLE EAST AND AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY TYPE OF RADIOISOTOPES, 2017–2027 REVENUE (USD MILLION)
91.    MIDDLE EAST AND AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY APPLICATION, 2017–2027 REVENUE (USD MILLION)
92.    UAE NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY TYPE OF RADIOISOTOPES, 2017–2027 REVENUE (USD MILLION)
93.    UAE NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY APPLICATION, 2017–2027 REVENUE (USD MILLION)
94.    SOUTH AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY TYPE OF RADIOISOTOPES, 2017–2027 REVENUE (USD MILLION)
95.    SOUTH AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY APPLICATION, 2017–2027 REVENUE (USD MILLION)
96.    SAUDI ARABIA NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY TYPE OF RADIOISOTOPES, 2017–2027 REVENUE (USD MILLION)
97.    SAUDI ARABIA NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY APPLICATION, 2017–2027 REVENUE (USD MILLION)
98.    REST OF MEA NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY TYPE OF RADIOISOTOPES, 2017–2027 REVENUE (USD MILLION)
99.    REST OF MEA NUCLEAR MEDICINE RADIOISOTOPES MARKET, BY APPLICATION, 2017–2027 REVENUE (USD MILLION)


LIST OF FIGURE
1.    RESEARCH DESIGN
2.    SCOPE OF THE STUDY
3.    GEOGRAPHIC SCOPE 
4.    CURRENCY CONSIDERATION 
5.    YEAR CONSIDERATION 
6.    MARKET ESTIMATION
7.    RESEARCH METHODOLOGY
8.    DATA TRIANGULATION
9.    COVID-19 IMPACT ON MARKET
10.    GLOBAL NUCLEAR MEDICINE RADIOISOTOPES  MARKET ATTRACTIVENESS ANALYSIS BY APPLICATION
11.    GLOBAL NUCLEAR MEDICINE RADIOISOTOPES  MARKET ATTRACTIVENESS ANALYSIS BY TYPE OF RADIOISOTOPES 
12.    GLOBAL NUCLEAR MEDICINE RADIOISOTOPES  MARKET ATTRACTIVENESS ANALYSIS BY REGION
13.    GLOBAL NUCLEAR MEDICINE RADIOISOTOPES  MARKET ATTRACTIVENESS ANALYSIS BY COUNTRY
14.    GLOBAL NUCLEAR MEDICINE RADIOISOTOPES  MARKET: DYNAMICS
15.    PESTEL ANALYSIS
16.    SWOT ANALYSIS 
17.    GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET ANALYSIS BY REGION
18.    GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET ANALYSIS BY APPLICATION
19.    GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET ANALYSIS BY TYPE OF RADIOISOTOPES
20.    GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET ANALYSIS BY NORTH AMERICA
21.    GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET ANALYSIS BY EUROPE
22.    GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET ANALYSIS BY ASIA PACIFIC
23.    GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET ANALYSIS BY SOUTH AMERICA
24.    GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET ANALYSIS BY MIDDLE EAST & AFRICA
25.    GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SHARE BY COMPANY (2019)
26.    NORTH AMERICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SHARE BY COMPANY (2019)
27.    EUROPE NUCLEAR MEDICINE RADIOISOTOPES MARKET SHARE BY COMPANY (2019)
28.    ASIA PACIFIC NUCLEAR MEDICINE RADIOISOTOPES MARKET SHARE BY COMPANY (2019)
29.    SOUTH AMERICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SHARE BY COMPANY (2019)
30.    MIDDLE EAST & AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SHARE BY COMPANY (2019)


 

Request For Research Methodology

To receive a sample copy of this report, please complete the form below

Kindly share your specific requirement (if any), so we can get back to you with a solution
Zenith Market Insights

Report Code

PHC21

Single User

US$ 3500

Multi User

US$ 5250

Corporate User

US$ 7000
Buy Now
Request Sample
Ask For Customization
Check Discount
Speak To Analyst
Enquiry Before Buying

Related Reports

Global Grinding Balls Market 2032

Price : $3500

Read more...

Global Cultured Meat Market-2032

Price : $3500

Read more...

Sandwich Panels Market

Price : $3500

Read more...

Baby Cradle Market

Price : $3500

Read more...

Flexible Office Market-2032

Price : $3500

Read more...

Brain Health Supplement Market

Price : $3500

Read more...

Dairy Testing Market -2032

Price : $3500

Read more...

Glass Bottles and Jars Decoration Market-2032

Price : $3500

Read more...

Instant Coffee Market 

Price : $3500

Read more...

Eco Fiber Market

Price : $3500

Read more...

Nuclear Medicine Radioisotopes Market By Type of R...

RD Code : PHC21

Buy Now

Zenith Market Insights

77563d33b4f7cc4dfa319a5f5ff07ec4.png

Connect with Us

Information

Quik Links

Our Contact

We Accept Payments

Subscribe News Letter